Camp4 Therapeutics Corporation
CAMP
$4.36
$0.163.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.50% | -166.80% | -19.96% | -1.24% | 6.37% |
| Total Depreciation and Amortization | 39.78% | -10.58% | -3.26% | 2.14% | 0.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.95% | 670.14% | 176.70% | -4.22% | 13.40% |
| Change in Net Operating Assets | -105.19% | 4,617.62% | -186.21% | 111.50% | -1,352.86% |
| Cash from Operations | -274.50% | 156.10% | -8.45% | 27.60% | -26.56% |
| Capital Expenditure | -- | -- | -- | 100.00% | -6.08% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | 100.00% | -6.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 83.78% | -254.17% | 147.68% | 28.44% |
| Issuance of Common Stock | -99.77% | -23.22% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -75.88% | -- | -- | -- |
| Cash from Financing | -99.80% | -39.67% | 65,711.11% | 147.68% | -100.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -131.32% | -3.66% | 452.48% | 30.21% | -123.92% |